European Society of Cardiology Core Curriculum for cardio-oncology.
Anticancer therapy
Cancer
Cardio-oncology
Cardiotoxicity
Chemotherapy
Hormonal therapy
Immunotherapy
Radiotherapy
Targeted therapies
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
07 Dec 2023
07 Dec 2023
Historique:
revised:
06
11
2023
received:
21
09
2023
accepted:
01
12
2023
pubmed:
7
12
2023
medline:
7
12
2023
entrez:
7
12
2023
Statut:
aheadofprint
Résumé
Cardio-oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted from the continuously increasing clinical demand for specialized CV evaluation, prevention and management of patients suffering or surviving from malignant diseases. Dealing with CV disease in patients with cancer requires special knowledge beyond that included in the general core curriculum for cardiology. Therefore, the European Society of Cardiology (ESC) has developed a special core curriculum for cardio-oncology, a consensus document that defines the level of experience and knowledge required for cardiologists in this particular field. It is structured into 8 chapters, including (i) principles of cancer biology and therapy; (ii) forms and definitions of cancer therapy-related cardiovascular toxicity (CTR-CVT); (iii) risk stratification, prevention and monitoring protocols for CTR-CVT; (iv) diagnosis and management of CV disease in patients with cancer; (v) long-term survivorship programmes and cardio-oncology rehabilitation; (vi) multidisciplinary team management of special populations; (vii) organization of cardio-oncology services; (viii) research in cardio-oncology. The core curriculum aims at promoting standardization and harmonization of training and evaluation in cardio-oncology, while it further provides the ground for an ESC certification programme designed to recognize the competencies of certified specialists.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of Health
Organisme : Horizon 2020
Informations de copyright
© 2023 European Society of Cardiology.
Références
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al.; ESC Scientific Document Group. ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022;2022:4229-4361. https://doi.org/10.1093/eurheartj/ehac244
Farmakis D. Is cardio-oncology a rapidly growing field of precision medicine? Eur J Heart Fail 2020;22:2310-2313. https://doi.org/10.1002/ejhf.2051
Pareek N, Cevallos J, Moliner P, Shah M, Tan LL, Chambers V, et al. Activity and outcomes of a cardio-oncology service in the United Kingdom - A five-year experience. Eur J Heart Fail 2018;20:1721-1731. https://doi.org/10.1002/ejhf.1292
Paterson DI, Wiebe N, Cheung WY, Mackey JR, Pituskin E, Reiman A, et al. Incident cardiovascular disease among adults with cancer: A population-based cohort study. JACC CardioOncol 2022;4:85-94. https://doi.org/10.1016/j.jaccao.2022.01.100
Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. N Engl J Med 2016;375:1457-1467. https://doi.org/10.1056/NEJMra1100265
Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, et al.; Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology. Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 2018;20:879-887. https://doi.org/10.1002/ejhf.1165
Caro-Codón J, López-Fernández T, Álvarez-Ortega C, Zamora Auñón P, Rodríguez IR, Gómez Prieto P, et al.; CARDIOTOX Registry Investigators. Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: Insights from the CARDIOTOX registry. Eur J Prev Cardiol 2022;29:859-868. https://doi.org/10.1093/eurjpc/zwaa034
Frank J, Snell L, Sherbino J. CanMEDS 2015 Physician Competency Framework. Ottawa: Royal College of Physicians and Surgeons of Canada; 2015.
Tanner FC, Brooks N, Fox KF, Gonçalves L, Kearney P, Michalis L, et al.; ESC Scientific Document Group. ESC Core Curriculum for the Cardiologist. Eur Heart J 2020;41:3605-3692. https://doi.org/10.1093/eurheartj/ehaa641
Hanahan D. Hallmarks of cancer: New dimensions. Cancer Discov 2022;12:31-46. https://doi.org/10.1158/2159-8290.CD-21-1059
Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, et al. Defining cardiovascular toxicities of cancer therapies: An International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J 2022;43:280-299. https://doi.org/10.1093/eurheartj/ehab674
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2768-2801. https://doi.org/10.1093/eurheartj/ehw211
Lyon AR, Dent S, Stanway S, Earl H, Brezden-Masley C, Cohen-Solal A, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: A position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur J Heart Fail 2020;22:1945-1960. https://doi.org/10.1002/ejhf.1920
Čelutkienė J, Pudil R, López-Fernández T, Grapsa J, Nihoyannopoulos P, Bergler-Klein J, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: A position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:1504-1524. https://doi.org/10.1002/ejhf.1957
Pudil R, Mueller C, Čelutkienė J, Henriksen PA, Lenihan D, Dent S, et al. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: A position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology. Eur J Heart Fail 2020;22:1966-1983. https://doi.org/10.1002/ejhf.2017
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al.; ESC Scientific Document Group. ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;2021:3227-3337. https://doi.org/10.1093/eurheartj/ehab484
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023;44:3627-3639. https://doi.org/10.1093/eurheartj/ehad195
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2021;2022:4-131. https://doi.org/10.1002/ejhf.2333
Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-3826. https://doi.org/10.1093/eurheartj/ehad191
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al.; ESC/EACTS Scientific Document Group. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2021;2022:561-632. https://doi.org/10.1093/eurheartj/ehab395
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021;42:373-498. https://doi.org/10.1093/eurheartj/ehaa612
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al.; ESC Scientific Document Group. ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019;2020:407-477. https://doi.org/10.1093/eurheartj/ehz425
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020;41:543-603. https://doi.org/10.1093/eurheartj/ehz405
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39:3021-3104. https://doi.org/10.1093/eurheartj/ehy339
Aboyans V, Ricco JB, Bartelink MLEL, Björck M, Brodmann M, Cohnert T, et al.; ESC Scientific Document Group. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763-816. https://doi.org/10.1093/eurheartj/ehx095
Wilhelm M, Abreu A, Adami PE, Ambrosetti M, Antonopoulou M, Biffi A, et al. EAPC Core Curriculum for Preventive Cardiology. Eur J Prev Cardiol 2022;29:251-274. https://doi.org/10.1093/eurjpc/zwab017
Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, et al.; American Heart Association Exercise, Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Peripheral Vascular Disease. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A scientific statement from the American Heart Association. Circulation 2019;139:e997-e1012. https://doi.org/10.1161/CIR.0000000000000679
Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G, et al. ESMO Expert consensus statements on cancer survivorship: Promoting high-quality survivorship care and research in Europe. Ann Oncol 2022;33:1119-1133. https://doi.org/10.1016/j.annonc.2022.07.1941
Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2017;35:893-911. https://doi.org/10.1200/JCO.2016.70.5400
Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 2021;23:512-526. https://doi.org/10.1002/ejhf.2140
Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, et al. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A consensus document of the Acute CardioVascular Care (ACVC) Association and the ESC Council of Cardio-Oncology - part 1: Acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute Cardiovasc Care 2021;10:947-959. https://doi.org/10.1093/ehjacc/zuab056
Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, et al. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A clinical consensus statement of the Acute CardioVascular Care Association (ACVC) and the ESC Council of Cardio-Oncology - part 2: Acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias. Eur Heart J Acute Cardiovasc Care 2022;11:865-874. https://doi.org/10.1093/ehjacc/zuac107
Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, Van der Meer P, et al. Cardio-Oncology Services: Rationale, organization, and implementation. Eur Heart J 2019;40:1756-1763. https://doi.org/10.1093/eurheartj/ehy453
Lee GA, Aktaa S, Baker E, Gale CP, Yaseen IF, Gulati G, et al. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. Eur Heart J Qual Care Clin Outcomes 2022;9:1-7. https://doi.org/10.1093/ehjqcco/qcac070
Hendriks JM, Lee G. Shared decision-making: The patient on the forefront of care coordination. Eur Heart J Qual Care Clin Outcomes 2020;6:231-233. https://doi.org/10.1093/ehjqcco/qcaa039
van der Velden J, Asselbergs FW, Bakkers J, Batkai S, Bertrand L, Bezzina CR, et al. Animal models and animal-free innovations for cardiovascular research: Current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2022;118:3016-3051. https://doi.org/10.1093/cvr/cvab370
de Boer RA, Hulot JS, Tocchetti CG, Aboumsallem JP, Ameri P, Anker SD, et al. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2020;22:2272-2289. https://doi.org/10.1002/ejhf.2029
Tocchetti CG, Ameri P, de Boer RA, D'Alessandra Y, Russo M, Sorriento D, et al. Cardiac dysfunction in cancer patients: Beyond direct cardiomyocyte damage of anticancer drugs: Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. Cardiovasc Res 2020;116:1820-1834. https://doi.org/10.1093/cvr/cvaa222
Boriani G, Lee G, Parrini I, Lopez-Fernandez T, Lyon AR, Suter T, et al.; 10.1093/eurjpc/zwaa054. Council of Cardio-Oncology of the European Society of Cardiology. Anticoagulation in patients with atrial fibrillation and active cancer: An international survey on patient management. Eur. J Prev Cardiol 2021;28:611-621.